Company | Sector | Market Cap | P/E Ratio | Latest Price | Last Updated |
|---|---|---|---|---|---|
FULC Fulcrum Therapeutics Inc | Healthcare | $721.72M | N/A | N/A | Feb 19, 2026 |
GDRX |
Healthcare |
| $763.94M |
| 24.78 |
| N/A |
| Mar 18, 2026 |
GRFS Grifols SA ADR | Healthcare | $7.65B | 13.81 | N/A | Jan 22, 2026 |
GUTS Fractyl Health, Inc. Common Stock | Healthcare | $66.42M | N/A | N/A | Feb 13, 2026 |
HIMS Hims Hers Health Inc | Healthcare | $4.86B | 41.84 | N/A | Mar 25, 2026 |
HOWL Werewolf Therapeutics Inc | Healthcare | $32.93M | N/A | N/A | Feb 4, 2026 |
IFRX InflaRx N.V. | Healthcare | $58.25M | N/A | N/A | Feb 17, 2026 |
IKT Inhibikase Therapeutics Inc | Healthcare | $119.23M | N/A | N/A | Mar 9, 2026 |
INDV Indivior PLC Ordinary Shares | Healthcare | $4.42B | 35.38 | N/A | Feb 2, 2026 |
ITRM Iterum Therapeutics PLC | Healthcare | $9.12M | N/A | N/A | Mar 13, 2026 |
KAPA Kairos Pharma, Ltd. | Healthcare | $17.63M | N/A | N/A | Jan 22, 2026 |
KIDS Orthopediatrics Corp | Healthcare | $416.34M | N/A | N/A | Mar 24, 2026 |
LGND Ligand Pharmaceuticals Incorporated | Healthcare | $3.62B | 81.34 | N/A | Feb 15, 2026 |
MAZE Maze Therapeutics, Inc. Common Stock | Healthcare | $2.17B | N/A | N/A | Feb 20, 2026 |
MBOT Microbot Medical Inc | Healthcare | $183.34M | N/A | N/A | Mar 17, 2026 |
MD Mednax Inc | Healthcare | $1.82B | 10.94 | N/A | Feb 8, 2026 |
MDWD Mediwound Ltd | Healthcare | $223.51M | N/A | N/A | Mar 18, 2026 |
MIRA MIRA Pharmaceuticals, Inc. Common Stock | Healthcare | $49.41M | N/A | N/A | Feb 13, 2026 |
MNDR Mobile-health Network Solutions Class A Ordinary Shares | Healthcare | $2.44M | N/A | N/A | Mar 7, 2026 |
NDRA ENDRA Life Sciences Inc | Healthcare | $5.11M | 0.18 | N/A | Mar 19, 2026 |
NMRA Neumora Therapeutics, Inc. | Healthcare | $448.64M | N/A | N/A | Mar 19, 2026 |
NTHI NeOnc Technologies Holdings, Inc. Common Stock | Healthcare | $226.04M | N/A | N/A | Mar 6, 2026 |
NUTX Nutex Health Inc | Healthcare | $831.66M | 5.74 | N/A | Mar 3, 2026 |
OBIO Orchestra BioMed Holdings Inc. | Healthcare | $216.26M | N/A | N/A | Feb 16, 2026 |
OMCL Omnicell Inc | Healthcare | $1.91B | 1038.25 | N/A | Mar 5, 2026 |
ONCO Onconetix Inc | Healthcare | $2.30M | 0.00 | N/A | Feb 5, 2026 |
OSTX OS Therapies Incorporated | Healthcare | $50.71M | N/A | N/A | Mar 26, 2026 |
OTLK OUTLOOK THERAPEUTICS INC | Healthcare | $32.42M | N/A | N/A | Feb 14, 2026 |
PAHC Phibro Animal Health Corporation | Healthcare | $2.18B | 23.81 | N/A | Mar 24, 2026 |
PGNY Progyny Inc | Healthcare | $1.52B | 27.53 | N/A | Mar 6, 2026 |
PHIO Phio Pharmaceuticals Corp | Healthcare | $15.79M | N/A | N/A | Mar 6, 2026 |
PHXM PHAXIAM Therapeutics S.A. | Healthcare | $28.90M | N/A | N/A | Feb 2, 2026 |
PLUR Pluri Inc. | Healthcare | $34.09M | N/A | N/A | Mar 15, 2026 |
PLX Protalix Biotherapeutics Inc | Healthcare | $243.68M | 37.88 | N/A | Feb 26, 2026 |
PMI Picard Medical, Inc. | Healthcare | $174.67M | N/A | N/A | Feb 16, 2026 |
POCI Precision Optics Corporation, Inc. Common stock | Healthcare | $38.73M | N/A | N/A | Jan 22, 2026 |
PODD Insulet Corporation | Healthcare | $15.99B | 65.83 | N/A | Mar 21, 2026 |
PRAX Praxis Precision Medicines Inc | Healthcare | $8.19B | N/A | N/A | Mar 16, 2026 |
PTCT PTC Therapeutics Inc | Healthcare | $5.41B | 7.82 | N/A | Mar 21, 2026 |
QSI QuantumSi Inc | Healthcare | $213.46M | N/A | N/A | Feb 16, 2026 |
QTRX Quanterix Corp | Healthcare | $179.31M | N/A | N/A | Mar 25, 2026 |
QTTB Q32 Bio Inc | Healthcare | $77.02M | N/A | N/A | Mar 11, 2026 |
QURE Uniqure NV | Healthcare | $1.12B | N/A | N/A | Mar 10, 2026 |
RANI Rani Therapeutics Holdings Inc | Healthcare | $163.12M | N/A | N/A | Mar 11, 2026 |
RBOT Vicarious Surgical Inc. | Healthcare | $3.13M | N/A | N/A | Mar 11, 2026 |
RCKT Rocket Pharmaceuticals Inc | Healthcare | $508.10M | N/A | N/A | Mar 26, 2026 |
REGN Regeneron Pharmaceuticals Inc | Healthcare | $82.64B | 18.83 | N/A | Feb 28, 2026 |
RNAC Cartesian Therapeutics Inc. | Healthcare | $169.28M | N/A | N/A | Mar 23, 2026 |
RVMD Revolution Medicines Inc | Healthcare | $19.50B | N/A | N/A | Mar 8, 2026 |
RXRX Recursion Pharmaceuticals Inc | Healthcare | $1.72B | N/A | N/A | Mar 22, 2026 |